AUS
NZ
UK
CA
USA
IND
Ansell Limited (ASX:ANN)
Ansell Limited (ASX: ANN) recently published a release containing important information with respect to the change of interests of the substantial holder. The release stated that BlackRock Group, a substantial holder of the group, has increased its voting power (with respect to the ordinary class of securities) from 6.45% to 7.63%. In another update, Ansell Limited had made an announcement related to the changes with respect to senior management. The release noted that Mr. Neil Salmon (CFO) is being appointed as the President of the Industrial GBU with effect from 30th April 2019. Also, Darryl Nazareth (Head of Research & Development for the Industrial GBU and Senior Vice President of Global Operations) is being appointed as the President of the Healthcare GBU. Mr. Zubair Javeed is joining the company as the new CFO effective from 29th April 2019. The joining of John Marsden as new Senior Vice President of Global Operations has also been highlighted in the release. The stock of Ansell Limited delivered the return of 14.25% in the span of the previous six months. At market close on April 24, 2019, the stock of Ansell Limited was trading at $26.870, up 2.479% during day trade with the intraday volume of 641,718.
Sonic Healthcare Limited (ASX:SHL)
Sonic Healthcare Limited (ASX: SHL) earlier released their earnings for the half-year ended December 2018, in which it posted a statutory net profit of A$223 million and revenues of A$2.9 billion. The top management of Sonic Healthcare Limited presented favourable views for the half-year performance and stated that the US, Swiss as well as Australian laboratory operations, particularly witnessed strong earnings growth. The company also informed that they have wrapped up the acquisition of Aurora Diagnostics in the month of January 2019. The release issued by the company also highlights that the key personnel of Sonic Healthcare will be working with Auroraâs management and pathologists to grow as well as enrich both the anatomical pathology and clinical laboratory operations of the expanded US business. The stocks of Sonic Healthcare delivered a return of 5.40% in the last six months. The market capitalisation of Sonic Healthcare Limited stands at $11.66 billion, with an annual dividend yield of 3.33%. At market close on April 24, 2019, the stock of Sonic Healthcare Limited was trading at $25.480, up 3.577% during day trade, with the PE multiple of 22.28x.
Healthscope Limited (ASX:HSO)
Healthscope Limited (ASX: HSO) release dated 23rd April 2019, reported that the group had completed the despatch of Transaction Booklet, which included the Bidderâs Statement with regards to the Takeover Bid. The latest release also noted the answer to the question âWhat is the Takeover Offer?â, the reference to $0.688, which was given in the Healthscope Transaction Booklet, has been replaced with $0.637 and reference to $0.691 has been replaced with $0.688. Also, the EBITDA forecast for 2021 for the year ended June 30, has been changed from $156.6 million to $456.6 million. As per the Australian Securities Exchange or ASX, the annual dividend yield of Healthscope Limited stands at 2.86% with a market capitalisation of $4.27 billion. The stock of Healthscope Limited delivered a return of 15.02% during the six-month period. At market close on April 24, 2019, the stock of Healthscope Limited was trading at $2.450 with the PE multiple of 17.190x.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
